Fingerprint

Dive into the research topics where Cancer Institute of New Jersey (CINJ), Hematologic Malignancies is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL

    Katz, D. A., Morris, J. D., Chu, M. P., David, K. A., Thieblemont, C., Morley, N. J., Khan, S. S., Viardot, A., Martín García-Sancho, A., Rodríguez-García, G., Bastos-Oreiro, M., Lee, S. T., Kormany, W., Chen, Y., Wong, H. L., Anderson, A. A., Katlinskaya, Y., Avilion, A. A., Dai, T. & González-Barca, E., 2022, (Accepted/In press) In: Leukemia and Lymphoma.

    Rutgers, The State University

    Research output: Contribution to journalArticlepeer-review

    Open Access
  • Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

    Orellana-Noia, V. M., Reed, D. R., McCook, A. A., Sen, J. M., Barlow, C. M., Malecek, M. K., Watkins, M., Kahl, B. S., Spinner, M. A., Advani, R., Voorhees, T. J., Snow, A., Grover, N. S., Ayers, A., Romancik, J., Liu, Y., Huntington, S. F., Chavez, J. C., Saeed, H., Lazaryan, A., & 33 othersRaghunathan, V., Spurgeon, S. E., Ollila, T. A., Del Prete, C., Olszewski, A., Ayers, E. C., Landsburg, D. J., Echalier, B., Lee, J., Kamdar, M., Caimi, P. F., Fu, T., Liu, J., David, K. A., Alharthy, H., Law, J., Karmali, R., Shah, H., Stephens, D. M., Major, A., Rojek, A. E., Smith, S. M., Yellala, A., Kallam, A., Nakhoda, S., Khan, N., Sohail, M. A., Hill, B. T., Barrett-Campbell, O., Lansigan, F., Switchenko, J., Cohen, J. & Portell, C. A., Jan 20 2022, In: Blood. 139, 3, p. 413-423 11 p.

    Rutgers, The State University

    Research output: Contribution to journalArticlepeer-review

    Open Access
  • Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

    Merryman, R. W., Redd, R. A., Nishihori, T., Chavez, J., Nieto, Y., Darrah, J. M., Rao, U., Byrne, M. T., Bond, D. A., Maddocks, K. J., Spinner, M. A., Advani, R. H., Ballard, H. J., Svoboda, J., Singh, A. K., McGuirk, J. P., Modi, D., Ramchandren, R., Romancik, J., Cohen, J. B., & 22 othersFrigault, M. J., Chen, Y. B., Serritella, A. V., Kline, J., Ansell, S., Nathan, S., Rahimian, M., Joyce, R. M., Shah, M., David, K. A., Park, S., Beaven, A. W., Habib, A., Bachanova, V., Nakhoda, S., Khan, N., Lynch, R. C., Smith, S. D., Ho, V. T., LaCasce, A., Armand, P. & Herrera, A. F., Mar 23 2021, In: Blood Advances. 5, 6, p. 1648-1659 12 p.

    Rutgers, The State University

    Research output: Contribution to journalArticlepeer-review

    Open Access
    2 Scopus citations